HARNESSING SENESCENCE FOR HUMAN HEALTHSPAN

Atropos aims to treat aging-related diseases and cancer and improve healthspan with approved novel senescence- targeting drugs.

Atropos, the Fate whose duty it was

to cut the threads of life.

 

Robert S. Holzman, MD

The Legacy of Atropos, the Fate Who Cut the Thread of Life, 1998

NEWS

June 11, 2020

Initial round of high throughput screening with Scripps Research Institute is completed and senosuppressor hits are currently being evaluated at Atropos.

©2018 by Atropos Therapeutics Inc.. Proudly created with Wix.com